127 related articles for article (PubMed ID: 749269)
1. Effect of fibrin degradation products on microvascular permeability.
Gerdin B; Saldeen T
Thromb Res; 1978 Dec; 13(6):995-1006. PubMed ID: 749269
[No Abstract] [Full Text] [Related]
2. Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin.
Gerdin B; Svensjö E
Int J Microcirc Clin Exp; 1983; 2(1):39-46. PubMed ID: 6088413
[TBL] [Abstract][Full Text] [Related]
3. Effect of fibrinogen degradation products on the rat blood vessels.
Buczko W
Acta Physiol Pol; 1977; 28(2):153-9. PubMed ID: 868533
[TBL] [Abstract][Full Text] [Related]
4. Effects of proteolytic degradation products of human fibrinogen and of human factor VIII on platelet aggregation and vascular permeability.
Stachurska J; Lopaciuk S; Gerdin B; Saldeen T; Korościk A; Kopeć M
Thromb Res; 1979; 15(5-6):663-72. PubMed ID: 494170
[No Abstract] [Full Text] [Related]
5. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive peptides derived from degradation of fibrinogen and fibrin.
Saldeen T
Ann N Y Acad Sci; 1983 Jun; 408():424-37. PubMed ID: 6575698
[No Abstract] [Full Text] [Related]
7. A peptide formed by fibrinolysis increases microvascular permeability and inhibits angiotensin converting enzyme.
Saldeen T; Ryan JW; Ragnarsson U
Adv Exp Med Biol; 1983; 156 (Pt B)():829-34. PubMed ID: 6305169
[No Abstract] [Full Text] [Related]
8. Quantitation of the inhibitory effect of fibrinogen and its degradation products on fibrin polymerization.
Belitser VA; Lugovskoy EV; Musjalkovskaja AA; Gogolinskaja GK
Thromb Res; 1982 Aug; 27(3):261-9. PubMed ID: 6291191
[TBL] [Abstract][Full Text] [Related]
9. Fibrin-derived vasoactive peptides release histamine.
Eriksson M; Saldeen K; Saldeen T; Strandberg K; Wallin R
Int J Microcirc Clin Exp; 1983; 2(4):337-45. PubMed ID: 6206010
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the permeability-increasing effect of bradykinin and substance P by a peptide derived from fibrinogen.
Eriksson M; Gerdin B; Saldeen T
Int J Microcirc Clin Exp; 1983; 2(1):53-9. PubMed ID: 6206007
[TBL] [Abstract][Full Text] [Related]
11. Regulation of extravascular coagulation by microvascular permeability.
Dvorak HF; Senger DR; Dvorak AM; Harvey VS; McDonagh J
Science; 1985 Mar; 227(4690):1059-61. PubMed ID: 3975602
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme dependent and non-dependent effects of a fibrinogen-derived pentapeptide on microvascular permeability in rat skin.
Eriksson M; Gerdin B; Saldeen T
Ups J Med Sci; 1983; 88(2):95-101. PubMed ID: 6316608
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of vasoactive peptides derived from fibrin or fibrinogen degraded by plasmin.
Belew M; Gerdin B; Lindeberg G; Porath J; Saldeen T; Wallin R
Biochim Biophys Acta; 1980 Feb; 621(2):169-78. PubMed ID: 7353036
[No Abstract] [Full Text] [Related]
14. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro.
Gramse M; Bingenheimer C; Schmidt W; Egbring R; Havemann K
J Clin Invest; 1978 Apr; 61(4):1027-33. PubMed ID: 77863
[TBL] [Abstract][Full Text] [Related]
15. Biological effects of fibrinogen-fibrin degradation products.
Larrieu MJ; Dray L; Ardaillou N
Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
[No Abstract] [Full Text] [Related]
16. Structural requirements for microvascular permeability-increasing ability of peptides. Studies on analogues of a fibrinogen pentapeptide fragment.
Gerdin B; Lindeberg G; Ragnarsson U; Saldeen T; Wallin R
Biochim Biophys Acta; 1983 Jun; 757(3):366-70. PubMed ID: 6849982
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant peptides obtained from human fibrinogen degradation products by plasmin.
Takagi K; Suzuki S; Kawai T
Thromb Res; 1979; 16(5-6):737-46. PubMed ID: 160628
[No Abstract] [Full Text] [Related]
18. Fibrin polymerization rate at different temperatures and in the presence of fragment D.
Belitser VA; Varetskaja TV; Musjalkovskaja AA
Thromb Res; 1981 Feb; 21(3):237-45. PubMed ID: 7245137
[No Abstract] [Full Text] [Related]
19. Effect of a fibrin(ogen)-derived vasoactive peptide on polymorphonuclear leukocyte emigration.
Saldeen K; Christie N; Nelson WR; Movat HZ
Thromb Res; 1985 Jan; 37(1):85-9. PubMed ID: 2984802
[TBL] [Abstract][Full Text] [Related]
20. Effects of nonspecific beta-adrenergic stimulation and blockade on blood coagulation in hypertension.
von Kanel R; Dimsdale JE; Adler KA; Dillon E; Perez CJ; Mills PJ
J Appl Physiol (1985); 2003 Apr; 94(4):1455-9. PubMed ID: 12482765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
